Part I. Central Nervous System Drugs Chapter 1: Drug Interactions with Benzodiazepines: Epidemiologic Correlates with Other CNS Depressants and In Vitro Correlates with Inhibitors and Inducers of Cytochrome P450 3A4 David E. Moody Chapter 2: Antiepileptic Drugs Nathan L. Kanous II and Barry E. Gidal Chapter 3: Opioids and Opiates Seyed-Adel Moallem, Kia Balali-Mood, and Mahdi Balali-Mood Chapter 4: Monoamine Oxidase Inhibitors and Tricyclic Antidepressants Terry J. Danielson Chapter 5: Selective Serotonin Reuptake Inhibitors Mojdeh Mozayani and Ashraf Mozayani Chapter 6: Antipsychotic Drugs and Interactions: Implications for Criminal and Civil Litigation Michael Welner Part II. Cardiovascular Drugs Chapter 7: Cardiovascular Drugs Johann Auer Part III. Antibiotics Chapter 8: Antimicrobial Drugs Amanda J. Jenkins and Jimmie L. Valentine Chapter 9: Drug Interactions with Medications Used for HIV/AIDS Michael Frank Part IV. Nonsteroidal Antiinflammatory Drugs Chapter 10: Nonsteroidal Antiinflammatory Drugs: Cyclooxygenase Inhibitors, Disease-Modifying Antirheumatic Agents, and Drugs Used in Gout Imad K. Abukhalaf, Daniel A. von Deutsch, Mohamed A. Bayorh, and Robin R. Socci Part V. Environmental and Social Pharmacology Chapter 11: Food and Drug Interactions Shahla M. Wunderlich Chapter 12: Alcohol and Drug Interactions A. Wayne Jones Chapter 13: Nicotine and Tobacco Edward J. Cone, Reginald V. Fant, and Jack E. Henningfield Chapter 14: Anabolic Doping Agents Daniel A. von Deutsch, Imad K. Abukhalaf, and Robin R. Socci Part VI. Legal Aspects Chapter 15: Drug Interaction Litigation Stephen A. Brunette Chapter 16: Psychotropic Medications and Crime: The Seasoning of the Prozac Defense Michael Welner Index